ABOUT VISTA PARTNERS

Vista Partners offers free, exclusive insight and research on the Dow 30 and Select Emerging Growth companies....

Browse Latest Coverage Learn More

Stay informed. Stay Competitive.

Vista Partners offers an exclusive newsletter and content with daily, weekly, monthly, and quarterly investing ideas, strategies, and market insights.





We value your privacy and will never share your information. Click here to learn more about all the great features offered in our newsletter.

The Latest

Vista Current Coverage

Breast Cancer Treatment Innovator Atossa Genetics Announces “A Productive First Six Months of 2018”

Seattle-based Atossa Genetics Inc. (ATOS) is  a clinical-stage biopharmaceutical company developing novel therapeutics and delivery methods to treat breast cancer and other breast conditions, announced their Q2 ended June 30, 2018, financial results and recent company developments which included the following: August 2018 – Contracted...

Dow 30 Component DowDuPont Announces Q2 Earnings

Dow 30 component DowDuPont (DWDP) reported their second quarter financial earnings of $1.37 per share on August 2, 2018. The company’s net sales saw a 17 percent increase to $24.4 billion. Agriculture sales rose 25 percent, Materials Science grew 18 percent, and the Specialty Products...

Dow 30

22,350
close
+0.4%
Week
+13.1%
YTD

Dow 30

22,350
close
+0.4%
Week
+13.1%
YTD

Dow 30

22,350
close
+0.4%
Week
+13.1%
YTD

Dow 30

22,350
close
+0.4%
Week
+13.1%
YTD

Dow 30

22,350
close
+0.4%
Week
+13.1%
YTD